Although there is no statistical difference in cardiac fibrosis between LDN-57444 treated and control hearts, there is a slight trend indicating LDN-57444 treatment might increase cardiac fibrosis after MI ( Fig. 2 D and E).
← all excerpts
UCHL1 protects against ischemic heart injury via activating HIF-1α signal pathway.
1
—
—